Aramco Backed Prosperity7 Ventures Leads Insilico Medicine $95M Series D

Today Insilico Medicine announced the completion of a second closing of its Series D round, led by Prosperity7 Ventures, the diversified growth fund of Saudi Aramco Ventures, bringing the total Series D financing to $95 million. Other global investors with expertise in the biopharmaceutical and life sciences sectors also participated. The financing brought in Prosperity7 as a new investor, alongside current investors in the Series D round, including a large, diversified asset management firm on the US West Coast, B Capital Group, Warburg Pincus, BHR Partners, Qiming Venture Partners, Deerfield, Pavilion Capital, BOLD Capital Partners, and WS Investment Company. Insilico's founder and CEO, Alex Zhavoronkov, PhD, also invested in the Series D round. Insilico Medicine plans to grow its presence in Saudi Arabia, building on the recent investment from Prosperity7.